The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characterization of responders to first line (chemo)immunotherapy in platinum-sensitive recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC).
 
Silvia Buriolla
No Relationships to Disclose
 
Stefano Cavalieri
No Relationships to Disclose
 
Andrea Franza
No Relationships to Disclose
 
Simone Rota
No Relationships to Disclose
 
Cristiana Bergamini
No Relationships to Disclose
 
Salvatore Alfieri
No Relationships to Disclose
 
Imperia Nuzzolese
No Relationships to Disclose
 
Elena Colombo
No Relationships to Disclose
 
Arianna Ottini
No Relationships to Disclose
 
Lisa F. Licitra
Consulting or Advisory Role - ACC Med+Logistics; Adlai Nortye; AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Debiopharm Group; Eisai; Exelixis; GlaxoSmithKline; IRX Therapeutics; Medpace; Merck Serono; MSD; Neutron Therapeutics; Novartis; Pfizer; Roche; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); IRX Therapeutics (Inst); Medpace (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst)
 
Carlo Resteghini
No Relationships to Disclose